Please login to the form below

Hanover Health launches the Mackay Programme

New programme for communicators looking to breakthrough in their careers.

Hanover Health has today launched The Mackay Programme to offer experienced professionals the opportunity to switch careers by joining an award-winning healthcare communications consultancy that helps to change the lives of millions for the better.

The programme, open to non-healthcare agency professionals and experienced communicators working in the wider healthcare sector, will provide comprehensive training and development to help propel successful candidates into a global healthcare communications career.

The selected candidates will join the Hanover Health team, who provide smart thinking, refreshing storytelling and breakthrough solutions to a wide range of global clients including: pharmaceutical and medical technology companies, healthcare service providers, charities, professional and public-sector bodies.

The programme will include:

· Fundamental training on our company, our services, our healthcare offer and how the business is run

· Industry-recognised training opportunities and participation in our Hanover Academy training programme

· Investment and budget to spend on CPD or professional qualifications to further career development

· Attendance at industry conferences and events

· The ability to draw on our network of experts in the sector (the Hanover Group is part of AVENIR GLOBAL, a global network of comms and public affairs consultancies)

· Opportunities to work with colleagues in our Brussels, Dublin and Middle East offices

· Immersion within an entrepreneurial environment

· Hanover Group benefits and additional perks

Successful candidates will be placed at levels ranging from Consultant up to Associate Director.

This opportunity is suited to those with a passion for communications and a drive to join a fast-paced, breakthrough industry.

Applicants must be able to demonstrate strong communications skills and an interest in the sector but no prior experience in healthcare is necessary. Applications close: Friday 10th April 2020. Shortlisted candidates will be invited to interview at the Hanover office in London.

The Mackay programme is dedicated to one of Hanover’s founders, Gregor Mackay, who died in 2005 eight weeks after being diagnosed with a rare form of cancer. Mackay personified an “uncommon sense” approach and took particular interest in the development of people and teams.

Andrew Harrison, Managing Director of Hanover Health, said:

“At Hanover Health, we recognise that the best innovation and creative problem-solving requires diverse thinking.

This is why we’re looking for the brightest minds across communications, public affairs and healthcare, to help bring fresh thinking, bold ideas and broad experience into the industry. The sector is constantly evolving, and this opportunity offers a different cohort of talent the chance to be part of this change, working with clients who are on the cusp of the latest research and technology to improve lives for the better.

It is only fitting to name it after Gregor Mackay, a man who personified the breakthrough approach, and who recognised the transformational power of great communications.”

For more information and to apply please visit www.hanovercomms.com or contact recruitment@hanovercomms.com.

-ends-

NOTES TO EDITORS

  1. Hanover Health’s team provides product and corporate communications, market access, policy and public affairs at an international and local level from its offices in London, Brussels, Dublin, Dubai and Abu Dhabi. Hanover Health is part of the wider Hanover Group. Hanover Group is part of the AVENIR GLOBAL group of companies. More information can be found at www.hanovercomms.com.

2. Hanover Health works with over half of the world’s top 20 pharmaceutical companies, as well as health technology businesses, trade associations, charities and healthcare providers. The fast-growing practice has been an important part of the Hanover Group’s overall expansion – a 25% average annual growth rate for the last five years.

3. Hanover Health won three prestigious industry awards in 2019: PharmaTimes International Team of the Year, EMEA Sabre Medical Technology and PRWeek Awards: Issues and Reputation Management.

4. Hanover Health is chaired by Sarah Matthew, co-founder of Virgo Health and one of the most influential figures in healthcare communications.

11th February 2020

Share

Tags

Company Details

Hanover Communications

+44 (0)20 7400 4480

Contact Website

Address:
70 Gray's Inn Road
London
WC1X 8BT
United Kingdom

Latest content on this profile

Let's be ambitious for patients and life sciences investment in Global Britain
“Take up of new medicines in the UK continues to be slow by international standards”. Since this Pharmaceutical Industry Competitiveness Task Force report in 2005, there have been at least five UK life science strategies plus three PPRS or VPAS deals. All have promised to accelerate access of new medicines to patients. Sadly, 12 years on, the 2017 Life Sciences Industrial Strategy could only restate the challenge: “Evidence demonstrates that access to and diffusion of products in the NHS is often slower than in some comparable countries”. Can we ever break this cycle? By Andrew Harrison, Group Managing Director of Hanover Health.
Hanover Communications
What is everyone ‘ARPAing on about?
On Wednesday 16th September, Ursula Von Der Leyen, President of the European Union, announced in her State of Union address that they plan to develop BARDA, a Biomedical Advanced Research and Development Agency. This follows on from the Conservative Government pledging in their manifesto in late 2019 to develop ARPA, the Advanced Research Projects Agency. Both of these agencies are direct descendants of DARPA, the Defense Advanced Research Projects Agency founded in the USA in 1958 to create “Nation technology-based options for preventing – and creating - technological surprise.” Technological surprise is a wonderfully euphemistic phrase which refers to military “surprise” in the context of the Cold War. However, in the context of a global pandemic and the politicisation of the race to find a vaccine many are now drawing Cold War comparisons. But can DARPA, ARPA or BARDA actually deliver technological surprise? Jennifer Blainey, Director, Hanover Health explores.
Hanover Communications
Tackling obesity via green prescribing: A piece of cake or a half-baked strategy?
In our new article, Lloyd Tingley explores the wider societal and behavioural factors that will impact the success of green prescribing and the obesity strategy, and the role companies will play in driving a society wide approach that impacts infrastructure, adherence, health inequalities, and more.
Hanover Communications
EU Pharmaceutical Strategy Roadmap
As discussed in a recent article, the next few years will define the future of life sciences and especially the regulation of breakthrough advanced therapy medicinal products (ATMPs) and orphan medicinal products (OMPs) in the EU. Here Senior Healthcare Director Emma Eatwell examines the impact of the recently-published European Commission Roadmap to develop an EU Pharmaceutical Strategy and considers what the the future looks like for ATMPs and OMPs.
Hanover Communications
Does digital primary care offer a sustainable solution?
After years in which the local GP surgery seemed stuck in the digital doldrums, the last few months have seen a digital revolution sweep across GP practices, driven by the extraordinary circumstances of the Coronavirus. NHS digital figures show that in 2019 less than one in every 100 GP appointments were carried out by online video consultation, and nearly 4 in 10 people had no access to online consultations at all. In the space of two months this has shifted, with GPs having to adapt to a new way of working while tackling the demands of a new disease. What does this all mean for the future of primary care? By Jack Turner, Senior Account Director, Hanover Healthcare.
Hanover Communications
Global communications during and post a worldwide pandemic: how can organisations break through the noise?
COVID-19 has understandably dominated the news agenda like no other story in a generation. But what about other disease areas that are both important and deserve public attention? How do we break through this wall, particularly as coronavirus looks set to govern the news agenda for the next few months at least, if not longer?
Hanover Communications